Maricopa Integrated Health System Installs Masimo Patient
SafetyNet™ System for Improved Oversight of General Floor
PHOENIX and IRVINE,
Calif., Nov. 15, 2012
/PRNewswire/ --Maricopa Integrated Health System, among the most
trafficked hospital systems in Arizona with more than 500 licensed beds,
and Masimo (NASDAQ: MASI) today announced that Maricopa has deployed Masimo Patient
SafetyNet™, clinically shown to help improve patient outcomes and
save money.1
The installation is part of the nationally recognized healthcare
organization's standardization to Masimo SET®
Measure-Through Motion and Low Perfusion pulse oximetry and
rainbow® SET® Pulse CO-Oximetry.
Maricopa joins a growing list
of leading health systems using Patient SafetyNet, which can help
ensure patient safety by noninvasively and continuously measuring
and tracking their underlying physiological conditions and detect
changes or abnormalities that signal declining health status in
real-time. When changes occur in the measured values, which may
indicate deterioration in the patient's condition, the system
automatically sends wireless alerts directly to clinicians –
prompting a potentially lifesaving response to the patient's
bedside.
"Patients and their families can be confident that with the
Masimo Patient SafetyNet system, they are being monitored at the
bedside even when clinical staff is not in the room," said Michael
O'Reilly, MD, Masimo's Chief Medical Officer. "We are honored that
Maricopa Integrated Health System has selected Masimo technology to
help protect their patients."
Maricopa patients also will
benefit from breakthrough rainbow® technology that
allows clinicians to measure multiple blood constituents,
respiration rate, and other physiological parameters without
invasive blood draws and time-consuming laboratory analysis.
Parameters in use include total hemoglobin (SpHb®),
oxygen content (SpOC™), carboxyhemoglobin (SpCO®),
methemoglobin (SpMet®), and Pleth Variability Index
(PVI®), in addition to the Measure-Through Motion and
Low Perfusion performance of Masimo SET® oxyhemoglobin
(SpO2), perfusion index (PI), and pulse rate (PR). The
pulse oximetry standard-of-care at leading hospitals worldwide,
Masimo SET® virtually eliminates false
alarms2 and increases a clinician's ability to detect
life-threatening events.3
Blood transfusions carry risks, including a significant link to
mortality, infection, and adult respiratory distress
syndrome.4 Masimo's SpHb has been clinically shown to
help anesthesiologists reduce the frequency of blood
transfusions.5
"I've found total hemoglobin (SpHb) to be particularly useful
when I'm in the OR because it offers a continuous measurement,"
said William Johnson, MD, Chairman
of the Department of Anesthesiology at Maricopa Medical Center. "In
cases where there's insidious blood loss during some of the longer
surgeries, you can keep track of the trend. And when there's
relatively rapid loss, the Masimo monitor produces a graph to show
hemoglobin falling. In either of those extremes, the ability to
track blood loss may make you more inclined not to give a unit of
blood when you can predict hemodynamics. When used properly, SpHb
can reduce the urge to give blood when it's not absolutely
necessary, which can improve patient safety and outcomes."
1 Taenzer A, Blike G, McGrath S, Pyke J, Herrick M,
Renaud C, Morgan J. "Postoperative Monitoring – The Dartmouth
Experience." Anesthesia Patient Safety Foundation Newsletter
Spring-Summer 2012. Available online
2 Shah N, Ragaswamy H, Govindugari K, Estanol L.
"Performance of three new-generation pulse oximeters during motion
and low perfusion in volunteers." Journal of Clinical
Anesthesia. 2012 (10.1016/j.jclinane.2011.10.012) Available
online here
3 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan
P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on
Rescue Events and Intensive Care Unit Transfers: A Before-and-After
Concurrence Study." Anesthesiology, February 2010, Vol. 112, Issue 2. Available
online here
4 Marik, P. E. and H. L.
Corwin (2008). "Efficacy of red blood cell transfusion in
the critically ill: a systematic review of the literature." Crit
Care Med 36(9): 2667-74.
5 Ehrenfeld JM, Henneman JP, Sandberg WS. "Impact of
Continuous and Noninvasive Hemoglobin Monitoring on Intraoperative
Blood Transfusions." American Society Anesthesiologists.
2010;LB05
About Maricopa Integrated Health System
Maricopa
Integrated Health System (MIHS) is the public health care system
for the State of Arizona. MIHS
includes Maricopa Medical Center, the Arizona Burn Center, the
Arizona Children's Center, the Arizona Cancer Center, and eleven
Family Health Centers located throughout Maricopa
County. MIHS also includes two behavioral health
centers and an attendant care program. For more information, please
visit www.mihs.org.
About Masimo
Masimo (NASDAQ: MASI) is the global
leader in innovative noninvasive monitoring technologies that
significantly improve patient care—helping solve "unsolvable"
problems. In 1995, the company debuted Measure-Through Motion and
Low Perfusion pulse oximetry, known as Masimo SET®,
which virtually eliminated false alarms and increased pulse
oximetry's ability to detect life-threatening events. More than 100
independent and objective studies have shown that Masimo
SET® outperforms other pulse oximetry technologies, even
under the most challenging clinical conditions, including patient
motion and low peripheral perfusion. In 2005, Masimo introduced
rainbow SET® Pulse CO-Oximetry technology, allowing
noninvasive and continuous monitoring of blood constituents that
previously required invasive procedures, including total hemoglobin
(SpHb®), oxygen content (SpOCTM),
carboxyhemoglobin (SpCO®), methemoglobin
(SpMet®), and Pleth Variability Index (PVI®),
in addition to SpO2, pulse rate, and perfusion index
(PI). Additional information about Masimo and its products may be
found at www.masimo.com.
Forward Looking Statements
This press release includes
forward-looking statements as defined in Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, in connection with the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are based on
current expectations about future events affecting us and are
subject to risks and uncertainties, all of which are difficult to
predict and many of which are beyond our control and could cause
our actual results to differ materially and adversely from those
expressed in our forward-looking statements as a result of various
risk factors, including, but not limited to: risks related to our
assumptions that the hospital-wide conversion ensures that all
Maricopa Integrated Health System patients will be cared for using
the most technologically and clinically-advanced noninvasive
patient monitoring solutions available; risks related to our belief
that Masimo Patient SafetyNet can help keep patients safer by
noninvasively, continuously measuring and tracking their underlying
physiological condition to help hospitals avoid preventable patient
deaths and injuries associated with failure to rescue events, risks
related to our assumptions of the repeatability of clinical results
obtained, and risks related to the system's ability to
significantly decrease traumatic critical events and costly ICU
transfers to help improve patient outcomes and reduce costs; risks
related to our belief that SpHb detects low or falling hemoglobin
levels that could be the result of internal bleeding; as well as
other factors discussed in the "Risk Factors" section of our most
recent reports filed with the Securities and Exchange Commission
("SEC"), which may be obtained for free at the SEC's website at
www.sec.gov. Although we believe that the expectations reflected in
our forward-looking statements are reasonable, we do not know
whether our expectations will prove correct. All forward-looking
statements included in this press release are expressly qualified
in their entirety by the foregoing cautionary statements. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of today's date. We do not
undertake any obligation to update, amend or clarify these
forward-looking statements or the "Risk Factors" contained in our
most recent reports filed with the SEC, whether as a result of new
information, future events or otherwise, except as may be required
under the applicable securities laws.
Media Contact:
Mike
Drummond
Masimo Corporation
Phone: (949) 297-7434
Email: mdrummond@masimo.com
Masimo, SET, Signal Extraction Technology, Improving Patient
Outcome and Reducing Cost of Care... by Taking Noninvasive
Monitoring to New Sites and Applications, rainbow, SpHb, SpOC,
SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7,
Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter,
Adaptive Threshold Alarm, and SEDLine are trademarks or registered
trademarks of Masimo Corporation. The use of the trademarks Patient
SafetyNet and PSN is under license from University HealthSystem
Consortium.
SOURCE Masimo